Atlas Trials

SKAMo-2: the Real-life Test of Continuous Photoacoustic Signal by Neogly in Patients With Type I Diabetes

Clinical trial NCT06035367 · UNKNOWN

Trial details

NCT number
NCT06035367
Sponsor
Eclypia
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Diabetes
Start date
2023-07-06
Primary completion
2023-10-30
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.